Morphic Holding Stock (NASDAQ:MORF), Quotes and News Summary

Q: What sector and industry does Morphic Holding (MORF) operate in?

Morphic Holding is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Morphic Holding Stock (NASDAQ: MORF) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 503.940K
Day Range	- - -
52 Wk Range	19.345 - 63.083
Market Cap	$1.377B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	17.04%
Days to Cover	18.33

Recent News

Gold Moves Lower; TransCode Therapeutics Shares Surge

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.07% to 33,939.93 while the NASDAQ rose 0.24% to 13,243.56. The S&P 500 also rose, gaining, 0.19% to 4,328.30.

Lisa Levin

Morphic Therapeutic's Stock Plunges On Monday - Here's Why?

Since Friday, Morphic Therapeutic (NASDAQ: MORF) shares have plunged from $47.92 to $26.25 after the company announced the publication of an abstract discussing new EMERALD-1 phase 2a primary results at United

Vandana Singh

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Morphic Holding Inc

Sector

Health Care

Industry

Biotechnology

Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Morphic Holding (MORF) stock?

You can purchase shares of Morphic Holding (NASDAQ: MORF) through any online brokerage.

View our list of the best stock brokerages.

Who are Morphic Holding's (MORF) competitors?

Other companies in Morphic Holding’s space includes: Twist Bioscience (NASDAQ:TWST), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Day One Biopharmaceutical (NASDAQ:DAWN) and Xencor (NASDAQ:XNCR).

What is the target price for Morphic Holding (MORF) stock?

The latest price target for Morphic Holding (NASDAQ: MORF) was reported by Canaccord Genuity on Friday, March 8, 2024. The analyst firm set a price target for 66.00 expecting MORF to rise to within 12 months (a possible 139.91% upside). 10 analyst firms have reported ratings in the last year.

Current Stock Price for Morphic Holding (MORF)?

The stock price for Morphic Holding (NASDAQ: MORF) is $27.51 last updated April 18, 2024 at 4:00 PM EDT.

Does Morphic Holding (MORF) pay a dividend?

There are no upcoming dividends for Morphic Holding.

When is Morphic Holding (NASDAQ:MORF) reporting earnings?

Morphic Holding’s Q1 earnings are confirmed for Tuesday, April 30, 2024.

Is Morphic Holding (MORF) going to split?

There is no upcoming split for Morphic Holding.

What sector and industry does Morphic Holding (MORF) operate in?

Morphic Holding is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-